BeiGene Co.,Ltd Announces Addition Of Dr. Ronald Levy To Scientific Advisory Board
3/3/2014 7:31:56 AM
BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the addition of Dr. Ronald Levy, M.D., to its Scientific Advisory Board. Dr. Levy is Professor of Medicine, Director of the Lymphoma Program and Former Chief of the Division of Oncology at Stanford University.
Help employers find you! Check out all the jobs and post your resume.
comments powered by